News

News Room

2023.12.13

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration
News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15

2843
News
Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

2023.08.14

2676
News
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

2023.05.09

3458
News
China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

2023.01.31

3795
News
In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

2022.08.30

3671
News
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

2022.03.25

3516
News
Happy 2022 and everything goes well

2021.12.31

4041
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

2021.11.10

4692
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01

4877
News
The Xiamen BNCT Center and Neuboron BNCT Group

2021.09.07

4581
News
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19

5535
News
China’s First BNCT Center Makes Debut

2021.02.09

4275
News
Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence

2020.12.09

4883
News
Neuboron Attends IAEA Technical Meeting on BNCT

2020.08.16

4666

Events

News Room

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

Happy 2022 and everything goes well

Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

The Xiamen BNCT Center and Neuboron BNCT Group

Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

China’s First BNCT Center Makes Debut

Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence

Neuboron Attends IAEA Technical Meeting on BNCT